Y-mAbs Therapeutics, Inc.
YMAB
$4.73
-$0.18-3.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.79M | -7.00M | -9.25M | -6.63M | -988.00K |
| Total Depreciation and Amortization | 102.00K | 121.00K | 153.00K | 159.00K | 161.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.04M | 3.02M | 3.67M | 4.34M | 2.23M |
| Change in Net Operating Assets | -1.22M | -6.80M | 5.72M | -1.35M | -9.44M |
| Cash from Operations | -1.87M | -10.67M | 298.00K | -3.48M | -8.04M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 986.00K | 979.00K | 1.76M | 588.00K | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 986.00K | 979.00K | 1.76M | 588.00K | 100.00K |
| Foreign Exchange rate Adjustments | -4.00K | 2.00K | 1.00K | 1.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -888.00K | -9.68M | 2.06M | -2.89M | -7.93M |
